Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (526) Agenerase (amprenavir), GlaxoSmithKline,
...Newly Approved Drug Therapies (526) Agenerase (amprenavir), GlaxoSmithKline, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Agenerase (amprenavir) Company: GlaxoSmithKline Approval Status: Approved April 1999 Treatment Area: Immunology/Infectious Diseases General Information AGENERASE ...
View Page

2. Clinical Trial Results by Drug Names
...A Controlled Phase II Trial Assessing 3 Doses of T-20 in Combination with Abacavir, Amprenavir, Ritonavir, and Efavirenz in HIV-Infected Adults Fast Facts: Protocol number: T20-206 Sponsor: Trimeris ...
...safety, efficacy, and plasma pharmacokinetics ( PK) of T-20 (Fuzeon) in combination with Abacavir (ABC), Amprenavir (APV), Ritonavir (RTV), and Efavirenz (EFV) in Human Immunodeficiency Virus Type-1 ( HIV-1) infected ...
View Page

3.  Study Posting (2348) Trial #82797, HIV, New York, NY
...Information A Phase I, Parallel, Open-Label, Multicenter, Two Week, Repeat-dose Study Evaluating Plasma Amprenavir Pharmacokinetics in HIV-1-Infected Adult Subjects with Mild or Moderate Hepatic Impairment Receiving Fosamprenavir ...
...edu A Phase I, Parallel, Open-Label, Multicenter, Two Week, Repeat-dose Study Evaluating Plasma Amprenavir Pharmacokinetics in HIV-1-Infected Adult Subjects with Mild or Moderate Hepatic Impairment Receiving Fosamprenavir ...
View Page

4. Clinical Trial Results: HIV Infections
...A Controlled Phase II Trial Assessing 3 Doses of T-20 in Combination with Abacavir, Amprenavir, Ritonavir, and Efavirenz in HIV-Infected Adults Product Name: Fuzeon [enfuvirtide] Date of Report: 10 ...
View Page

5. Advanced/Specific Search Results Fuzeon [enfuvirtide]
...A Controlled Phase II Trial Assessing 3 Doses of T-20 in Combination with Abacavir, Amprenavir, Ritonavir, and Efavirenz in HIV-Infected Adults Product Name: Fuzeon [enfuvirtide] Date of Report: 10 ...
View Page

6.  Newly Approved Drug Therapies (844) Lexiva (fosamprenavir calcium), GlaxoSmithKline,
...new protease inhibitor (PI) for the treatment of HIV infection. It is a prodrug of amprenavir, an inhibitor of human immunodeficiency virus (HIV) protease. Lexiva is indicated for the treatment of ...
...the following: • • Diarrhea • Nausea • Vomiting • Headache • Rash Mechanism of Action Fosamprenavir is rapidly converted to amprenavir, an inhibitor of HIV-1 protease, by cellular phosphatases in vivo. Amprenavir binds to the ...
View Page

7.  Study Posting (2380) Trial #157521, Erectile Dysfunction, Lawrenceville, NJ
...recent drug abuse • hypoactive sexual desire • premature ejaculation • Con meds: • Erythromycin • Intraconazole, ketoconazole • Ritonavir, saquinavir, amprenavir, indinavir, nelfinavir • Cimetidine • Anticoagulants • Trazodone AdvanceMed Research 2 Princess Rd., Suite J Lawrenceville, NJ 8648 ...
View Page

8.  Newly Approved Drug Therapies (880) Aptivus (tipranavir), Boehringer Ingelheim,
...an optimum background regimen (OBR), or a control regimen of an approved protease inhibitor (lopinavir, amprenavir, saquinavir or indinavir) in combination with ritonavir plus OBR for 24 weeks. Trial data indicated ...
...TC, Galli M, Rusconi S. Analysis of protease inhibitor combinations in vitro: activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates. Journal of Antimicrobial ...
View Page

9.  Study Posting (1918) Trial #160135, Metastatic Cancer, Savannah, GA
...and no concurrent CYP3A4 inhibitors, including any of the following: • HIV protease inhibitors (e.g., amprenavir, atazanavir, fosamprenavir, indinavir, nelfinavir, ritonavir) • Select antibiotics (e.g., ciprofloxacin, clarithromycin, doxycycline, enoxacin, isoniazid, telithromycin ...
View Page

10.  Study Posting (1918) Trial #160134, Breast Cancer, Savannah, GA
...and no concurrent CYP3A4 inhibitors, including any of the following: • HIV protease inhibitors (e.g., amprenavir, atazanavir, fosamprenavir, indinavir, nelfinavir, ritonavir) • Select antibiotics (e.g., ciprofloxacin, clarithromycin, doxycycline, enoxacin, isoniazid, telithromycin ...
View Page

11.  Newly Approved Drug Therapies (988) Aptivus (tipranavir), Boehringer Ingelheim,
...of ritonavir plus optimal backgroumd therapy (OBR) or a ritonavir-boosted protease inhibitor (PI) (lopinavir, amprenavir, saquinavir or indinavir) plus OBR. The studies evaluated treatment response at 48 weeks. Through 48 ...
View Page

12.  CenterWatch: Clinical Trials in Category (417) HIV
...Center A Phase I, Parallel, Open-Label, Multicenter, Two Week, Repeat-dose Study Evaluating Plasma Amprenavir Pharmacokinetics in HIV-1-Infected Adult Subjects with Mild or Moderate Hepatic Impairment Receiving Fosamprenavir ...
View Page

13.  CenterWatch: List of Newly Approved Drug Thearapies
...Poulenc Rorer; Treatment for acute deep vein thrombosis, Approved January 1999 Immunology/Infectious Diseases Agenerase (amprenavir) ; GlaxoSmithKline; For the treatment of HIV-1 infection., Approved April 1999 Cleocin (clindamycin phosphate) ; Pharmacia ...
View Page

14.  CenterWatch: Immunology/Infectious Diseases Approved Drug Therapies
...For the treatment of HIV-1 infection, Approved November 2000 Drugs Approved in 1999 Agenerase (amprenavir) ; GlaxoSmithKline; For the treatment of HIV-1 infection., Approved April 1999 Cleocin (clindamycin phosphate) ; Pharmacia ...
View Page